Dr. John Oertle of Envita Medical Centers Presents Innovative Alternatives to Prostate Cancer Surgery on AZ Family

The removal of the prostate, which is typically considered the first line of curative treatment for prostate cancer, may not always be successful in eradicating the cancer. “Research shows that in one-third of the men, there is actually a return of the PSA (Prostate-Specific Antigen), meaning the cancer is back,” said Dr. John Oertle, Chief Medical Officer of Envita Medical Centers.

Speaking on a news segment marking “Prostate Cancer Awareness Month,” Dr. Oertle explained that men are often not prepared for the risks and complications, such as urinary incontinence, that are associated with this surgery. “The good news is that there are alternatives,” added Dr. Oertle. He reiterated that the innovative and advanced approach of precision integrative oncology, followed by the team of specially trained physicians at Envita, is aimed at avoiding invasive surgeries when possible and countering their risks.

Discussing the embolization procedure used at Envita, Dr. Oertle said, “We can go directly to where the tumor is, inject it with specific medications, and then embolize the actual vessels... It stops the blood supply to the tumor and allows the tumor to shrivel on up.” Embolization using personalized medications is just one of the many tools available for prostate cancer patients at Envita. With this unique and comprehensive approach, the Envita team has been able to help many cancer patients recover holistically, regardless of their type or stage of cancer.

To learn more about the early signs and symptoms of prostate cancer, tips to reduce its risk, and how the Envita team utilizes advanced tools to treat it, watch this AZ Family news segment.